CAR-T therapy is currently available in Spain for the treatment of certain types of blood cancer, such as relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). The availability of CAR-T therapy in Spain may vary depending on the hospital or clinic providing the treatment, as well as the patient's eligibility for the therapy.
In Spain, the use of CAR-T therapy is regulated by the Spanish Agency of Medicines and Medical Devices (AEMPS), which oversees the approval and monitoring of all medical treatments and devices in the country. AEMPS has approved several CAR-T therapies for use in Spain, including tisagenlecleucel and axicabtagene ciloleucel for the treatment of certain types of blood cancer. The availability of CAR-T therapy in Spain may also depend on the patient's insurance coverage, as CAR-T therapy can be expensive. However, the Spanish healthcare system provides coverage for medical treatments, including CAR-T therapy, through the National Health System (Sistema Nacional de Salud).
Overall, the availability of CAR-T therapy in Spain is improving, with more hospitals and clinics offering the treatment and more patients being eligible for the therapy. However, access to CAR-T therapy may still be limited for some patients due to factors such as cost and eligibility criteria.
The cost of CAR-T cell therapy in Spain
The cost of CAR-T therapy in Spain can vary depending on the specific therapy being used, the hospital or clinic providing the treatment, and the patient's insurance coverage. However, CAR-T therapy is generally expensive due to its complex manufacturing process and personalized nature.
In Spain, the cost of CAR-T therapy for the treatment of blood cancer can range from tens of thousands to hundreds of thousands of euros. For example, the cost of tisagenlecleucel, a CAR-T therapy approved in Spain for the treatment of certain types of blood cancer, has been reported to be around €320,000 (approximately 380,000 US dollars) per treatment.
However, as I mentioned earlier, the Spanish healthcare system provides coverage for medical treatments, including CAR-T therapy, through the National Health System (Sistema Nacional de Salud). This means that patients who are covered by the public health insurance system in Spain may not have to pay the full cost of CAR-T therapy out of pocket. Private insurance may also cover some or all of the cost of CAR-T therapy, depending on the specific policy.
Here are some hospitals and clinics in Spain that offer CAR-T therapy:
• Hospital Clínic de Barcelona • Hospital Universitario 12 de Octubre in Madrid • Hospital Universitario Ramón y Cajal in Madrid • Hospital Universitario La Fe in Valencia • Hospital Vall d'Hebron in Barcelona
CAR-T cell therapy in Israel
CAR-T for Leukemia and Lymphoma in Israel
CAR-T for Myeloma in Israel
CAR-T cell therapy for leukemia and non-Hodgkin's lymphoma (NHL) in Europe
CAR-T cell therapy for Multiple Myeloma patients in Europe